Amphastar Pharmaceuticals, Inc. (AMPH)

Amphastar Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	98.09	159.52	137.55	91.39	62.12
Depreciation & Amortization	63.2	57.21	41.78	28.28	26.53
Other Amortization	3.36	6.03	11.4	0.47	0.22
Loss (Gain) From Sale of Assets	0.04	0.01	0.48	0.14	-13.24
Asset Writedown & Restructuring Costs	-	-	2.7	-	-
Loss (Gain) From Sale of Investments	2.49	-2.79	5.33	-2.2	0.03
Loss (Gain) on Equity Investments	-	0.57	1.98	1.18	0.21
Stock-Based Compensation	27.28	24.37	20.24	17.86	18.69
Other Operating Activities	27.63	-16.98	-13.74	-15.75	5.39
Change in Accounts Receivable	-6.37	-21.67	-26.09	-10.13	-14.92
Change in Inventory	-21.06	-48.8	-1.72	-11.75	1.26
Change in Accounts Payable	-4.56	63.56	13.24	-0.74	3.63
Change in Income Taxes	-24.84	6.83	-3.32	-4.56	8.35
Change in Other Net Operating Assets	-9.14	-14.48	-6.32	-5.01	-0.27
Operating Cash Flow	156.12	213.39	183.5	89.18	97.99
Operating Cash Flow Growth	-26.84%	16.29%	105.77%	-8.99%	71.12%
Capital Expenditures	-34.88	-41.04	-38.17	-24.03	-27.46
Sale of Property, Plant & Equipment	-	-	-	0.42	-
Cash Acquisitions	-	-129	-506.41	-	-
Sale (Purchase) of Intangibles	-2.25	-	-	-	-
Investment in Securities	-28.84	49.23	-105.93	-7.79	1.4
Other Investing Activities	-4.36	-4.12	1.39	-1.37	-2.61
Investing Cash Flow	-70.33	-124.93	-649.12	-32.78	-28.67
Long-Term Debt Issued	6.22	18.43	845	-	70
Long-Term Debt Repaid	-0.22	-8.26	-318.66	-1.78	-37.9
Net Debt Issued (Repaid)	5.99	10.17	526.34	-1.78	32.1
Issuance of Common Stock	2.86	-	10.97	15.66	15.93
Repurchase of Common Stock	-75.59	-90.31	-58.14	-39.91	-28.87
Other Financing Activities	-0.69	-0.82	-25.08	-0.41	-56.17
Financing Cash Flow	-67.43	-80.95	454.09	-26.44	-37.02
Foreign Exchange Rate Adjustments	0.21	-0.19	-0.28	-0.22	-0.22
Net Cash Flow	18.57	7.31	-11.8	29.75	32.08
Free Cash Flow	121.23	172.35	145.34	65.15	70.54
Free Cash Flow Growth	-29.66%	18.58%	123.09%	-7.64%	201.30%
Free Cash Flow Margin	16.84%	23.54%	22.55%	13.06%	16.11%
Free Cash Flow Per Share	2.51	3.31	2.74	1.24	1.42
Cash Interest Paid	23.22	26.81	17.57	3.02	2.11
Cash Income Tax Paid	22.71	40.1	49	44.44	8.1
Levered Free Cash Flow	81.37	18.89	241.41	57.67	56.9
Unlevered Free Cash Flow	96.62	34.94	250.67	58.36	57.23
Change in Working Capital	-65.97	-14.55	-24.21	-32.18	-1.95

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q